Ensysce Biosciences, Inc.

ENSC ·Healthcare, Drug Manufacturers - General, United States

SEC Filings

Form	Filed	Description
8-K	Apr 3, 2026	8-K
10-K	Mar 30, 2026	10-K
8-K	Mar 30, 2026	8-K
8-K	Mar 30, 2026	8-K
8-K	Mar 23, 2026	8-K
8-K	Feb 27, 2026	8-K
8-K	Jan 8, 2026	8-K
DEFA14A	Dec 16, 2025	DEFA14A
EFFECT	Dec 11, 2025
CORRESP	Dec 9, 2025
S-3	Dec 2, 2025	S-3
ARS	Dec 2, 2025	ARS
DEF 14A	Dec 2, 2025	DEF 14A
PRE 14A	Nov 21, 2025	PRE 14A
8-K	Nov 17, 2025	8-K
10-Q	Nov 14, 2025	10-Q
8-K	Nov 14, 2025	8-K
424B5	Nov 14, 2025	424B5
10-Q	Aug 13, 2025	10-Q
8-K	Aug 13, 2025	8-K
SCHEDULE 13G/A	Aug 12, 2025
8-K	Jun 5, 2025	8-K
SCHEDULE 13G/A	May 15, 2025
10-Q	May 13, 2025	10-Q
8-K	May 13, 2025	8-K

← Newer Page 2 of 22 · 545 filings Older →